Amyloid fibril toxicity in Alzheimer's disease and diabetes

Annals of the New York Academy of Sciences

Volumn 777, Issue , 1996, Pages 89-95

  Lorenzo, A ^a   Yankner, B A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; CONGO RED;

ALZHEIMER DISEASE; ANIMAL CELL; BRAIN NERVE CELL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FETUS; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PANCREAS ISLET CELL; RAT; SYNAPSE;

ANIMALIA;

EID: 0029964207     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb34406.x     Document Type: Conference Paper

References (12)

1. ROHER, A. E., M. J. BALL, S. V. BHAVE & A. R. WAKADE. 1991. β-amyloid from Alzheimer's disease brain inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 174:572-579.
2. YANKNER, B. A., L. R. DAWES, S. FISHER, L. VILLA-KOMAROFF, M. L. OSTER-GRANITE & R. L. NEVE. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420.
3. YANKNER, B. A., L. K. DUFFY & D. A. KIRSCHNER. 1990. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279-282.
4. YANKNER, B. A. 1992. Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol. Aging 13:615-616.5.
5. BUSCIGLIO, J., A. LORENZO & B. A. YANKNER. 1992. Methodological variables in the assessment of β amyloid neurotoxicity. Neurobiol. Aging 13:609-612.
6. MATTSON, M. P., K. J. TOMASELLI & R. E. RYDEL. 1993. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:35-49.
7. PIKE, C. J., D. BURDICK, A. J. WALENCEWICZ, C. G. GLABE & C. W. COTMAN. 1993. Neurodegenertion induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687.
8. PIKE, C. J., A. J. WALENCEWICZ, C. G. GLABE & C. W. COTMAN. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314.
9. LORENZO, A. & B. A. YANKNER. 1994. Beta amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91: 12243-12247.
10. LORENZO, A., B. RAZZABONI, C. WEIR & B. A. YANKNER. 1994. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368: 756-760.
11. JOHNSON, K. H., T. D. O'BRIEN, C. BETSHOLTZ & P. WESTERMARK. 1989. Islet amyloid, islet amyloid polypeptide, and diabetes mellitus. New Engl. J. Med. 321:513-518.
12. MAY, P. C., L. N. BOGGS & K. S. FUSON. 1993. Neurotoxicity of human amylin in rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid-beta neurotoxicity. J. Neurochem. 61:2330-2333.